Dr. Wei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue
Boston, MA 02215- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2011 - 2013
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
NH State Medical License 2024 - 2024
MA State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer Start of enrollment: 2018 Oct 18
Roles: Principal Investigator, Contact
- Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy Start of enrollment: 2020 Dec 10
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors Start of enrollment: 2020 May 11
Roles: Principal Investigator, Contact, Sponsor-Investigator
Publications & Presentations
PubMed
- Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna May...> ;Cancer Immunology Research. 2024 Mar 29
- 1 citationsPretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.Huma Q Rana, Jill E Stopfer, Michelle Weitz, Lindsay Kipnis, Diane R Koeller, Samantha Culver, Joanna Mercado, Rebecca Sue Gelman, Meghan Underhill-Blazey, Bradley A M...> ;JCO Oncology Practice. 2023 Nov 1
- IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer.Praful Ravi, Victoria Wang, Raina N Fichorova, Bradley McGregor, Xiao X Wei, Shehzad Basaria, Christopher J Sweeney> ;Endocrine-Related Cancer. 2023 Nov 1
- Join now to see all
Press Mentions
Efficient Catalytic Reduction of Highly Toxic Aqueous Cr(VI) with Fe@CBC/Pd Composites at Room TemperatureOctober 16th, 2020
Professional Memberships
- Member
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
